The World Health Organization (WHO) on Thursday issued an emergency use listing for the single-dose Covid-19 vaccine from China-based CanSino Biologics.

The vaccine, Convidecia, is the eleventh shot against the coronavirus to get clearance from the global health agency, whose advisory group recommended its use in people of age 18 years and above.

The vaccine was found to have 64 percent efficacy against symptomatic disease and 92 percent against severe Covid-19, the agency said.

Other vaccines that have similar clearance from the agency include those made by Pfizer Inc and BioNTech, Moderna Inc, AstraZeneca Plc, Johnson & Johnson and Novavax Inc.

- Reuters

FDA to soon authorise Pfizer's Covid booster shot for younger kids

FDA to soon authorise Pfizer's Covid booster shot for younger kids

N Korea's Kim orders military to stabilise supply of Covid drugs

N Korea's Kim orders military to stabilise supply of Covid drugs

N Korea reports more deaths, takes 'swift measures' against Covid-19 outbreak

N Korea reports more deaths, takes 'swift measures' against Covid-19 outbreak

Immunocompromised teens can get booster 4 months after primary vaccine

Immunocompromised teens can get booster 4 months after primary vaccine

Covid-19 vaccine makers shift focus to boosters

Covid-19 vaccine makers shift focus to boosters